BPA Call 75D30123A17284-75D30125F20431
Award Date
1/22/25
Potential Completion Date
9/30/25
Potential Value
$88K
Federal Agency
CDC Pittsburgh
Awardee
Zen-Bio, Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27713, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Zen-Bio, Inc., doing business as Zenbio, was awarded a $33,435 firm fixed price contract by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. This contract is a call order under a larger Blanket Purchase Agreement (BPA) held by Zenbio with the CDC, which was originally awarded on September 19, 2023 and has an ultimate completion date of September 19, 2024. The BPA is specifically for the procurement of blood units and related services to support the CDC's...
The Department of Health and Human Services Centers for Disease Control and Prevention (HHS-CDC) in Pittsburgh awarded a $100,010 firm fixed price blanket purchase agreement (BPA) call contract to Zen-Bio, Inc., doing business as Zenbio, located in Durham, North Carolina. Under the terms of the BPA, Zenbio will provide unspecified ZEN-BIO FUNDING BASE services to CDC in support of its disease prevention and health promotion efforts. The single award is for a three-month period of performance...
This firm fixed-price purchase order contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the Department of Health and Human Services, to Zen-Bio, Inc. (doing business as Zenbio) on July 25, 2024. The $19,044 contract requires Zenbio to provide cord blood CD34+/CD133+ cells to support NHLBI's Maternal and Child Health Bureau (MCHB) in developing novel gene therapy strategies through cell culture experiments. This award is not associated with any set-aside...
This contract, awarded by the Defense Health Agency (DHA) to Zen-Bio, Inc. (Zenbio), provides screened human blood products to support malaria vaccine research conducted by the Walter Reed Army Institute of Research (WRAIR). The $206,163 firm fixed-price award covers the delivery of O+ packed red blood cells every two weeks and A+ human male serum on a monthly basis. This contract is not set-aside and was competitively awarded. Zenbio, a for-profit manufacturer of human blood products, has...
This is a firm fixed-price definitive contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Zen-Bio, Inc. (doing business as Zenbio), a for-profit manufacturer of human blood products and related biological services. The $224,901 contract is for high content screening to identify human primary pancreatic cell type-specific toxicants. This is a small business set-aside contract with a completion date of March 14, 2016. Zenbio has been...
This is a $9,720 firm-fixed-price call order issued under a Blanket Purchase Agreement (BPA) contract with the Centers for Disease Control and Prevention (CDC). The prime contractor is Lifesouth Community Blood Centers Inc., a non-profit organization that provides blood collection, processing, and distribution services to federal agencies. The BPA was awarded on August 7, 2023 and has a total ceiling value of $96,428, with a period of performance through August 3, 2028. Under this BPA, the CDC...
This federal contract award, valued at $16,020.00, was issued by the Centers for Disease Control and Prevention (CDC) to Lifesouth Community Blood Centers Inc., a non-profit organization that specializes in blood collection, processing, and distribution services. The contract is a Blanket Purchase Agreement (BPA) for cord blood services, supporting the CDC's ongoing public health research and initiatives. This is not a set-aside contract. Lifesouth has prior experience working with the CDC and...
The Centers for Disease Control and Prevention (CDC) awarded a $249,662 purchase order to Cell Microsystems Inc. to procure cell lines in support of the agency's biomedical research and public health initiatives. The firm fixed price contract has a period of performance from September 11, 2023 through October 30, 2023 for delivery of the requested cell lines to CDC facilities in Durham, North Carolina. No subcontractors or set aside designations were identified. This award advances the CDC's...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Lampire Biological Labs Inc., a for-profit manufacturer specializing in custom antibodies, blood products, tissues, organs, and reagents. The $919,988 firm fixed price definitive contract is to supply red blood cells from horses, turkeys, and guinea pigs to the CDC's location in Pittsburgh, Pennsylvania over a performance period from September 22, 2023 to September 21, 2026. Lampire has also...
This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Lifesouth Community Blood Centers Inc., a non-profit organization specializing in blood collection, processing, and distribution services. The contract, valued at $75,000.00, is for the processing, division, and shipment of 500 blood samples to two divisions of the CDC. The award does not have a set-aside designation. Lifesouth Community Blood Centers Inc. has a proven track record of...